A Applied Therapeutics, Inc.: management transactions · United States · SEC (Form 4) Browse the full directors' dealings record of Applied Therapeutics, Inc., a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 17 June 2025 (Attribution). Among the most active insiders: Funtleyder Leslie D.. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 17 June 2025
All Executives29 Thresholds0 Prospectus0 Other0
Declarations 29 total
◆ Chief Medical Officer · Executives · 15 Jun 2025
300,000 shares 0Common Stock SEC:0000950170-25-087356:0
◆ See Remarks · Executives · 24 Mar 2025
350,000 shares 0Common Stock SEC:0000950170-25-045613:0
◆ See Remarks · Executives · 24 Mar 2025
350,000 shares 0Common Stock SEC:0000950170-25-045609:0
◆ Chief Commercial Officer · Executives · 24 Mar 2025
250,000 shares 0Common Stock SEC:0000950170-25-045617:0
▼ See Remarks · Executives · 4 Mar 2025
447 shares @ US$0.44 1.1% of flow Common Stock SEC:0000950170-25-035040:0
▼ See Remarks · Executives · 4 Mar 2025
14,502 shares @ US$0.44 2.0% of flow Common Stock SEC:0000950170-25-035041:0
▼ Chief Medical Officer · Executives · 4 Mar 2025
10,366 shares @ US$0.44 0.5% of flow Common Stock SEC:0000950170-25-035043:0
▼ See Remarks · Executives · 6 Feb 2025
28,117 shares @ US$0.61 98.9% of flow Common Stock SEC:0000950170-25-016585:0
▼ See Remarks · Executives · 6 Feb 2025
22,950 shares @ US$0.61 4.5% of flow Common Stock SEC:0000950170-25-016588:0
▼ Chief Medical Officer · Executives · 6 Feb 2025
86,078 shares @ US$0.61 6.3% of flow Common Stock SEC:0000950170-25-016587:0
◆ Executive Chairman · Executives · 19 Dec 2024
500,000 shares 0Common Stock SEC:0000950170-24-139240:0
◆ See Remarks · Executives · 19 Dec 2024
150,000 shares 0Common Stock SEC:0000950170-24-139239:0
▼ Chief Medical Officer · Executives · 22 Aug 2024
22,681 shares @ US$5.83 14.8% of flow Common Stock SEC:0000950170-24-100218:0
▼ Chief Financial Officer · Executives · 22 Aug 2024
13,530 shares @ US$5.83 23.7% of flow Common Stock SEC:0000950170-24-100222:0
● President and CEO · Executives · 5 Aug 2024
747,886 shares 0Common Stock SEC:0000950170-24-097309:0
▼ Chief Financial Officer · Executives · 6 Jun 2024
16,980 shares @ US$4.32 22.5% of flow Common Stock SEC:0000950170-24-071325:0
▼ Chief Medical Officer · Executives · 6 Jun 2024
22,003 shares @ US$4.32 10.8% of flow Common Stock SEC:0000950170-24-071329:0
▼ President and CEO · Executives · 6 Jun 2024
61,795 shares @ US$4.32 13.5% of flow Common Stock SEC:0000950170-24-071333:0
◆ Director · Executives · 6 Jun 2024
45,000 shares 0Common Stock SEC:0000950170-24-070634:0
◆ Director · Executives · 6 Jun 2024
45,000 shares 0Common Stock SEC:0000950170-24-070668:0
◆ Director · Executives · 6 Jun 2024
45,000 shares 0Common Stock SEC:0000950170-24-070638:0
◆ Director · Executives · 6 Jun 2024
45,000 shares 0Common Stock SEC:0000950170-24-070614:0
150,000 shares @ US$4.21 100.0% of flow Common Stock SEC:0001035443-24-000171:0
◆ Chief Commercial Officer · Executives · 12 Apr 2024
300,000 shares 0Common Stock SEC:0000950172-24-000190:0
▼ Chief Financial Officer · Executives · 14 Mar 2024
28,727 shares @ US$5.39 47.2% of flow Common Stock SEC:0001096906-24-000491:0
25 of 29 declarations
Load more (4 remaining)